Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950005-02-000301
Filing Date
2002-03-12
Accepted
2002-03-12 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT p15086_10k.txt 10-K 213440
3 SERVICES AGREEMENT p15086_ex10-12.txt EX-10.12 104067
4 FUNDING ARRANGEMENT p15086_ex10-13.txt EX-10.13 32153
5 SHARE PURCHASE AGREEMENT p15086_ex10-14.txt EX-10.14 208254
6 CONSENT OF ERNST & YOUNG LLP p15086_ex23-1.txt EX-23 1224
  Complete submission text file 0000950005-02-000301.txt   561160
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 02573691
SIC: 2834 Pharmaceutical Preparations